The number of shares and votes in Vimian Group AB (publ) (“Vimian”) has changed as a result of conversion of in total 7,446,367 C-shares into ordinary shares carried out in June following requests from shareholders in accordance with the conversion clause in Vimian’s articles of association.

Pursuant to agreements entered into between Vimian and certain shareholders in connection with the restructuring conducted in connection with the listing in 2021, the C-shares will vest over a three-year period. Conversion of the 7,446,367 C-shares relates to vesting of the third of the C-shares. Additional conversion of C-shares may be carried out upon request from holders of C-shares.

Following the conversion, there are in total 522,420,366 shares in Vimian (of which 517,032,379 are ordinary shares and 5,387,987 are C-shares), carrying in total 517,571,177.7 votes in Vimian.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.

Attachments

Conversion of C-shares in Vimian Group AB

© Modular Finance, source Nordic Press Releases